This AMERSA webinar brings together three voices from Colorado working at different levels of the methadone treatment system: the State Opioid Treatment Authority (SOTA), a pioneering addiction medicine physician leading a satellite methadone clinic, and a methadone patient engaged in statewide advocacy. Together, they will share how policy, practice, and lived experience intersect to drive reform. Their collaborative work offers a model for other states seeking to expand life-saving methadone access.
Panelists:
Paul Christine, MD, PhD, is an internal medicine physician and addiction specialist who provides integrated primary care and addiction treatment at the University of Colorado and Denver Health. His research focuses on evaluating and implementing health and social policies that improve the health of people use drugs.
Andrew Goodman, BA, CPFS passionately advocates for evidence-based interventions for individuals with SUD, rooted in compassion and the principles of harm reduction. His work as a Community Navigator for the Denver Department of Public Health & Environment, and Board Member at the National Coalition to Liberate Methadone & the Colorado Drug Policy Coalition focuses on reducing stigma & barriers to care associated with Medications for Opioid Use Disorder within Opioid Treatment Programs.
Ryan Mueller, M.Ed, LPC, LAC currently serves as Colorado’s State Opioid Treatment Authority within the state's Behavioral Health Administration, directing regulation and licensure of methadone treatment programs and withdrawal management programs. A significant function of his role is collaborating with state partners and providers to expand access to care and improve health equity in Colorado. Receiving his M.Ed from the University of Missouri, Ryan is a licensed professional counselor and licensed addiction counselor, with eighteen years’ experience in the behavioral health field, ranging from direct clinical care, system leadership, and regulatory oversight. The values that drive his work are compassion, justice, and advocacy.
Facilitator:
Rachel Winograd, PhD, is an Associate Professor at the University of Missouri St. Louis. Currently, she directs the UMSL Addiction Science team and serves as Principal Investigator of the Addiction Science, Practice, Implementation, Research, & Education (ASPIRE) Lab. Dr. Winograd and her teams’ efforts primarily focus on expanding access to medical treatment, harm reduction strategies, and person-centered approaches for those most in need of evidence-based care for substance use disorders in Missouri.
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}